Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Nonlinear Pharmacokinetics: Causes of Nonlinearity01:22

Nonlinear Pharmacokinetics: Causes of Nonlinearity

Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding01:22

Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding

When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Siderophore-producing bacteria reduce soil cadmium bioavailability and alleviate cadmium stress in alfalfa.

Ecotoxicology and environmental safety·2026
Same author

Anthracene-Based Rare-Earth MOF Assembly for Photocatalytic Cr(VI) Reduction and Dye Degradation.

Inorganic chemistry·2026
Same author

Large-scale imaging genetics reveals causal effects of brain microstructure across the epilepsy spectrum.

Neurobiology of disease·2026
Same author

A Hybrid Machine Learning Framework to Improve Morphological Trait Recovery in Avian Datasets.

Ecology and evolution·2026
Same author

Delayed but durable remission to rituximab in PLA2R-associated membranous nephropathy despite B-cell reconstitution: a case report.

BMC nephrology·2026
Same author

Mechanistic insights into ultrasonic vibration-induced avoidance behavior of fouling organisms on Ti alloy surfaces.

Ultrasonics·2026
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

Biological pathway selection through nonlinear dimension reduction.

Hongjie Zhu1, Lexin Li

  • 1Bioinformatics Research Center and Department of Statistics, North Carolina State University, Box 8203, Raleigh, NC 27695, USA.

Biostatistics (Oxford, England)
|January 22, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces a novel two-step method to identify biological pathways influencing clinical outcomes from high-throughput data. The approach effectively analyzes gene interactions and pathway effects, outperforming existing methods.

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

Related Experiment Videos

Last Updated: Jun 5, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

Area of Science:

  • Bioinformatics
  • Statistical Genetics
  • Systems Biology

Background:

  • High-throughput biological data analysis often assumes genes interact within pathways.
  • Leveraging prior pathway knowledge can enhance statistical analysis and interpretation of complex biological data.
  • Identifying pathways linked to clinical phenotypes is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To develop a robust statistical framework for identifying pathways associated with clinical phenotypes.
  • To improve the interpretation and estimation in the analysis of high-dimensional biological data using pathway information.
  • To propose a novel two-step procedure for pathway analysis in clinical data.

Main Methods:

  • A two-step procedure involving nonlinear dimension reduction for within-pathway gene interactions and nonlinear pathway effects.
  • Development of a regularized model-based approach for pathway ranking and selection using extracted summary features.
  • Application of the method to glioblastoma microarray data.

Main Results:

  • The proposed method demonstrates favorable performance compared to existing solutions in simulation studies.
  • Identified 4 pathways significantly associated with clinical phenotypes in glioblastoma data.
  • The nonlinear dimension reduction effectively captures complex gene-gene interactions within pathways.

Conclusions:

  • The novel two-step method provides an effective approach for pathway-based analysis of high-throughput biological data.
  • This method facilitates the identification of clinically relevant pathways, aiding in biomarker discovery and therapeutic target identification.
  • The findings highlight the importance of incorporating pathway knowledge and nonlinear modeling in biological data analysis.